KindlyMD Q2 revenue down 34.8% to $639K; insurance reimbursement up 163.7% sequentially

Nakamoto Inc.

2024-Q2 EPS reported -$0.33 revenue$1,468,086

Revenue $639K, down 34.8% YoY due to shift from cash-pay to insurance billing.
Insurance reimbursements $91.6K in Q2, up 163.7% sequentially; six-month total $126K vs $0 prior year.
Net loss per share $(0.26) vs $(0.13) in Q2 2023; operating expenses up 6%.
Completed IPO in June 2024, net proceeds $6.02M; cash $4.74M at June 30.
Now covering nearly 80% of Utah's insured population under contracts with Medicare, Select Health, Medicaid, BCBS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.